Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (3y) (2012 - 2018)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (3y) (2012 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -0.96% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | -65.41% |
| Dec 31, 2017 | -31.61% |
| Sep 30, 2017 | -25.21% |
| Jun 30, 2017 | 4.89% |
| Mar 31, 2017 | 5.94% |
| Dec 31, 2016 | 7.83% |
| Sep 30, 2016 | 8.80% |
| Jun 30, 2016 | 4.97% |
| Mar 31, 2016 | 2.99% |
| Dec 31, 2015 | 10.66% |
| Sep 30, 2015 | 6.59% |
| Jun 30, 2015 | 7.78% |
| Mar 31, 2015 | 18.56% |
| Dec 31, 2014 | 12.70% |
| Sep 30, 2014 | 12.96% |
| Jun 30, 2014 | 13.78% |
| Mar 31, 2014 | 12.75% |
| Dec 31, 2013 | 17.07% |
| Sep 30, 2013 | 16.49% |
| Jun 30, 2013 | 17.79% |